ArticleAnnals of nuclear medicine2021

Cardiovascular event risk estimated after coronary revascularization and optimal medical therapy: J-ACCESS4 prognostic study.

Tomohiko Sakatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.